Effect of nebulized epoprostenol (prostacyclin) on exhaled nitric oxide in patients with pulmonary hypertension due to congenital heart disease and in normal controls.

MLA

Forrest, I. A., et al. “Effect of Nebulized Epoprostenol (Prostacyclin) on Exhaled Nitric Oxide in Patients with Pulmonary Hypertension Due to Congenital Heart Disease and in Normal Controls.” Clinical Science (London, England : 1979), vol. 97, no. 1, July 1999, pp. 99–102. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10369800&authtype=sso&custid=ns315887.

APA

Forrest, I. A., Small, T., & Corris, P. A. (1999). Effect of nebulized epoprostenol (prostacyclin) on exhaled nitric oxide in patients with pulmonary hypertension due to congenital heart disease and in normal controls. Clinical Science (London, England : 1979), 97(1), 99–102.

Chicago

Forrest, I A, T Small, and P A Corris. 1999. “Effect of Nebulized Epoprostenol (Prostacyclin) on Exhaled Nitric Oxide in Patients with Pulmonary Hypertension Due to Congenital Heart Disease and in Normal Controls.” Clinical Science (London, England : 1979) 97 (1): 99–102. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10369800&authtype=sso&custid=ns315887.